PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biophore India Pharmaceuticals PVT. Ltd

USPTO PatentsView assignee record - 23 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07B (General Methods OF Organic CHEMISTRY; Apparatus Therefor).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biophore ranks #12,837 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 15 technology areas.

#12,837
of 49,997 US assignees by volume
31st percentile
by Innovation Score (29.4/100)
7.0
avg claims per patent
+33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12837 · Foreign Corporation #12,837 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 23 grants
  • MID-PACK #12,837/49,997
  • PHOTO-FINISH Beijing Zhigu Tech
  • CPC-FOCUS C07B · 15 areas
  • INNOV-THIN 29.4/100
  • CLAIMS-SPARSE 7.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Zhigu Tech Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biophore’s 29.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Biophore

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biophore's Innovation Score is 29.4/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Biophore?

Each dot is one of Biophore’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biophore’s own 7.0 claims/patent is at or below the 18.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biophore vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 22.922.92323.1 051015202530 Granted patents (volume) Avg claims / patent Beijing Zhigu Tech Co., Ltd. - 23, 25.39Beijing Zhigu TechBernafon AG - 23, 18.43BernafonBharat Biotech International Limited - 23, 21.39Bharat Biotech In…Biocartis, NV - 23, 14.87BiocartisBlue SKY Innovation Group, Inc. - 23, 3.78Blue SKY Innovati…Blueshift Materials, Inc. - 23, 21.09Blueshift Materia…Bobst Bielefeld GMBH - 23, 14.35Bobst BielefeldBoegli-gravures SA - 23, 18.57Boegli-gravuresBiophore India Pharmaceuticals PVT. Ltd - 23, 7.04Biophore India Ph…
Biophore vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biophore's grants concentrate

Biophore India Pharmaceuticals PVT. Ltd is a focused PatentsView assignee: 15 CPC subclasses with 39.1% of grants classified under C07B (General Methods OF Organic CHEMISTRY; Apparatus Therefor). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2015. By volume, Biophore sits between Beijing Zhigu Tech Co., Ltd. and Boegli-gravures SA.

Biophore's three-year grant acceleration

Biophore India Pharmaceuticals PVT. Ltd shows 1 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Biophore's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biophore holds 23 patents at rank #12,831, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biophore

By rank, the assignees closest to #12,831 in granted patent volume.

Leaders in C07B (General Methods OF Organic Chemistry)

Other assignees with the most granted patents in Biophore's primary technology class.

Biophore's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 31st percentile higher than 31% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152017201820192020202120222025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biophore India Pharmaceuticals PVT. Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 4.3%
2017 3 13.0%
2018 3 13.0%
2019 2 8.7%
2020 5 21.7%
2021 6 26.1%
2022 1 4.3%
2025partial year 2 8.7%

Which technologies does Biophore India Pharmaceuticals PVT. Ltd patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biophore India Pharmaceuticals PVT. Ltd's patent record in context - here's where to go next.

  • Biophore India Pharmaceuticals PVT. Ltd's lead technology class is C07B (General Methods OF Organic CHEMISTRY; Apparatus Therefor), 39.1% of its portfolio - see every assignee active in that class. Explore C07B
  • Ranked #12,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biophore India Pharmaceuticals PVT. Ltd against Beijing Zhigu Tech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 29.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.